Two live educational webinars

 

The new European HS guidelines mastered

 

Image
Hero_wide_bg@2x copy.png
Image
mobile banner

These live educational webinars are organised and funded by UCB. They are intended for EU healthcare professionals only.

Are you a healthcare professional who wants to learn more about how the new European S2k guidelines are transforming hidradenitis suppurativa (HS) care?

We invite you to join our live educational webinars,* streaming during HS awareness week – 'From guidelines to action: Transforming HS treatment pathways' (Tuesday, 3 June, 18:00–19:00 CEST) and 'Shared decisions: Redefining HS treatment' (Thursday, 5 June, 18:00–19:00 CEST). These webinars will deep dive into the recently published European S2k guidelines (2025) for HS, allowing you to gain practical insights into implementing the guidelines and learn how to effectively integrate patient perspectives to formulate personalised treatment plans.

 

Engage with expert speakers in a live Q&A session and benefit from real time translation (French, German, Italian , Spanish) for an interactive and accessible learning experience.

 

 

 

*Pending CPD accreditation approval.

 

HIDRACENSUS 7.3 at a glance 

 

HIDRACENSUS 7.3 is an ongoing, pan-European, expert-led programme, sponsored by UCB, that aims to improve the standard of care for patients living with HS through education and best practice sharing. If you would like to learn more about our HIDRACENSUS 7.3 programme, then visit our HIDRACENSUS 7.3 page.

Why 7.3?

It takes a staggering 7.3 years, on average, for patients to receive a correct diagnosis 

of HS.1,2   

Webinar 1 – From guidelines to action: Transforming HS treatment pathways

 

Tuesday, 3 June, 18:00–19:00 CEST

 

This webinar will focus on optimisation of HS treatment by exploring the optimal 'window of opportunity’ for early medical intervention and identify the critical role that a combined surgical and medical approach may play in the management of some patients.

 

Meet our esteemed speakers for Webinar 1

Dr Hessel van der Zee


Dermatologist, Erasmus MC and DermaHaven, Rotterdam, Netherlands

 

Van Der Zee Circular Headshot size.png

Professor Monika Arenbergerová


Associate Professor, Department of Dermatovenereology, Third Faculty of Medicine, Charles University, Prague, Czech Republic


 

Arenbergerova Circular Headshot.png

Webinar 2 – Shared decisions: Redefining HS treatment

 

Thursday, 5 June, 18:00–19:00 CEST

 

This webinar will discuss how to deliver personalised hidradenitis suppurativa (HS) care by exploring the use of patient-reported outcomes in management decisions, the importance of holistic care in HS and how to facilitate supportive consultations to address patient concerns and expectations.

 

Meet our esteemed speakers for Webinar 2

Dr Aikaterini Liakou


Dermatologist-Venereologist, 1st Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Faculty of Medicine, “Andreas Sygros” Hospital for Cutaneous and Venereal Diseases, Athens, Greece
Liakou circular headshot.png

Professor Francesca Prignano


Associate Professor, Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy

 

Professor Francesca Prignano copy.png

Download this flyer  to invite your colleagues to the two HS Awareness Week webinars.

 

Visit the HS learning hub to access our comprehensive suite of educational materials, including our expert-led webinars.

 

Discover practical tools available on our Resources page, designed to enhance your HS management.

 

 

Once you register, you'll receive a confirmation email. Please note that your registration will only be confirmed after we verify your HCP status.

 

 

CPD, Continuing Professional Development; EU, European Union; HCP, healthcare professional; HS, hidradenitis suppurativa.

References
  1. Barmatz S, et al. Dermatology. 2022;238:772–84.
  2. Nguyen TV, et al. J Eur Acad Dermatol Venereol. 2021;35:50–61.

© UCB Biopharma SRL, 2025. All rights reserved.

EU-DA-2500164 | Date of preparation: May 2025